Mohammad Luqman

Title: Innovations by Inventor Mohammad Luqman

Introduction

Mohammad Luqman is an accomplished inventor based in Acton, MA (US). He has made significant contributions to the field of allergen research, particularly focusing on therapeutic and diagnostic peptides. With a total of 2 patents, his work has the potential to impact the treatment of allergies related to ryegrass pollen.

Latest Patents

Luqman's latest patents include innovations related to T cell epitopes of ryegrass pollen allergen. The first patent provides isolated peptides of Lol p V, a major protein allergen of the species Lolium perenne. These therapeutic peptides comprise at least one T cell epitope, or preferably at least two T cell epitopes of the protein allergen. Additionally, diagnostic peptides bind IgE, which is crucial for allergy diagnosis. The invention also includes modified peptides that possess similar or enhanced therapeutic properties while reducing side effects. Furthermore, it provides nucleic acid sequences coding for these peptides, facilitating the development of medicaments for treating sensitivity to Lol p V or related allergens.

Career Highlights

Throughout his career, Luqman has worked with notable companies such as Heska Corporation and Immunologic Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in allergen research and peptide development.

Collaborations

Luqman has collaborated with esteemed colleagues, including Irwin J Griffith and Mei-chang Kuo. These partnerships have likely enriched his research and innovation efforts.

Conclusion

In summary, Mohammad Luqman is a notable inventor whose work on allergen-related peptides has the potential to advance therapeutic options for individuals suffering from allergies. His contributions to the field are significant and reflect his dedication to innovation.